Popular Categories
The PATH to Combatting Antimicrobial Resistance
By Natalie Mulloy, NACCHO Government Affairs Intern According to the Centers for Disease Control and Prevention (CDC), antibiotic or...
Aug 05, 2016 | Kim Rodgers
NIH Launches Large Clinical Trials of Antibody-Based HIV Prevention
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), has begun studies on three...
Apr 08, 2016 | Alyson Jordan
FDA Approves Zepatier for Treatment of Chronic Hepatitis C for Genotypes 1 and 4
The U.S. Food and Drug Administration approved Zepatier with or without ribavirin for the treatment of chronic hepatitis C virus (HCV)...
Jan 28, 2016 | Alyssa Kitlas
Lessons for Local Health Departments from the International Conference on Emerging...
The International Conference on Emerging Infectious Diseases (ICEID) was held in Atlanta at the end of August and Jackie Lawler, an...
Oct 13, 2015 | Christina Baum
Visit the New PrEPWatch.org — A Global Clearinghouse on PrEP
AVAC recently redesigned and updated www.prepwatch.org. The site is designed to be a clearinghouse for information on PrEP research...
Oct 09, 2015 | Gretchen Weiss
CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines
Last week, the CDC released a press release to welcome the announcement by the World Health Organization (WHO) of new Early Release...
Oct 08, 2015 | Alyssa Kitlas
San Francisco is Changing the Face of AIDS Treatment
Last year, San Francisco had only 302 new HIV diagnoses, the lowest recorded number. In 1992, at the epidemic’s peak, there were 2,332...
Oct 05, 2015 | Alyssa Kitlas
The PATH to Combatting Antimicrobial ResistanceBy Natalie Mulloy, NACCHO Government Affairs Intern According to the Centers for Disease Control and Prevention (CDC), antibiotic or antimicrobial resistance is one of the most pressing health challenges in our nation. Antibiotic or antimicrobial resistance occurs when microbes are able to spread despite the treatment of drugs, placing individuals at high risk for death. Recently, an […] Aug 05, 2016 | Kim Rodgers |
NIH Launches Large Clinical Trials of Antibody-Based HIV PreventionThe National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), has begun studies on three continents that could have broad implications for HIV prevention research. Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the […] Apr 08, 2016 | Alyson Jordan |
FDA Approves Zepatier for Treatment of Chronic Hepatitis C for Genotypes 1 and 4The U.S. Food and Drug Administration approved Zepatier with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) for genotypes 1 and 4 in adults. An estimated 3.5 million people in the United States are infected with chronic HCV and genotype 1 is the most common genotype. The safety and efficacy of Zepatier […] Jan 28, 2016 | Alyssa Kitlas |
Lessons for Local Health Departments from the International Conference on Emerging Infectious DiseasesThe International Conference on Emerging Infectious Diseases (ICEID) was held in Atlanta at the end of August and Jackie Lawler, an epidemiologist at the Orange County Health Department in New York and a member of NACCHO’s Infectious Disease Prevention and Control Workgroup, attended as the NACCHO partner representative on the ICEID 2015 Scientific Program Committee. […] Oct 13, 2015 | Christina Baum |
Visit the New PrEPWatch.org — A Global Clearinghouse on PrEPAVAC recently redesigned and updated www.prepwatch.org. The site is designed to be a clearinghouse for information on PrEP research (ongoing and completed; clinical trials and demonstration projects), data, additional research, cost, access, and advocacy efforts across the globe. PrEPWatch will continue to evolve, and AVAC would like your input as it takes shape. Contact them at [email protected] if... Oct 09, 2015 | Gretchen Weiss |
CDC Supports New WHO Early Release HIV Treatment and PrEP GuidelinesLast week, the CDC released a press release to welcome the announcement by the World Health Organization (WHO) of new Early Release HIV Treatment and Pre-Exposure Prophylaxis (PrEP) guidelines. This press release stated that these guidelines will significantly increase the number of people eligible for life-saving anti-retroviral treatment (ART) and expand access to a powerful tool for […] Oct 08, 2015 | Alyssa Kitlas |
San Francisco is Changing the Face of AIDS TreatmentLast year, San Francisco had only 302 new HIV diagnoses, the lowest recorded number. In 1992, at the epidemic’s peak, there were 2,332 diagnoses. Eighty-two percent of residents with HIV currently are in care, and 72 percent are virally suppressed, results that are much higher than national averages. The city’s chief strength has been a willingness […] Oct 05, 2015 | Alyssa Kitlas |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOW
